A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
KMOV St. Louis on MSN11h
Nasal COVID vaccine developed at WashU approved for clinical trialsThe Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
A nasal vaccine for COVID-19 – based on technology developed at ... after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...
Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway.
Louisville Public Media on MSN3d
Yes to raw milk, no to fluoride: Some Ky Republicans skeptical of public health initiativesSeveral Kentucky bills filed this legislative session have one thing in common: a shared skepticism of guidance from top U.S.
Kennedy Jr. as Health and Human Services secretary—a key victory for one of President Donald Trump’s most controversial cabinet picks, after some GOP lawmakers remained on-the-fence due to Kennedy’s ...
Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback